• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的多重耐药菌感染:一项流行病学研究。

Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.

机构信息

a State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine , Zhejiang University , Hangzhou , Zhejiang Province , China.

出版信息

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1167-1174. doi: 10.1080/17474124.2018.1515627. Epub 2018 Sep 5.

DOI:10.1080/17474124.2018.1515627
PMID:30152255
Abstract

BACKGROUND

The purpose of this study is to describe the epidemiological features of bacterial infections caused by multidrug-resistant (MDR) bacteria in cirrhotic patients and their impact on mortality.

METHODS

A retrospective study of cirrhotic patients with culture-confirmed bacterial infections was performed between 2011 and 2017.

RESULTS

A total of 635 episodes in 563 patients with cirrhosis were included. Bacterial infections caused by MDR isolates accounted for 44.1% (280/635) of the episodes, nearly half of which were hospital acquired (48.4%). The most common MDR isolation site was the respiratory tract (36.4%, 102 episodes), followed by the abdominal cavity (35.4%, 99 episodes). Of the MDR isolates, carbapenem-resistant Enterobacteriaceae (CRE) (91 episodes) were the most common. Patients infected with MDR bacteria had significantly higher mortality than those not infected (25.1% vs 17.4%, p = 0.025). However, this increased mortality could be largely attributed to methicillin-resistant Staphylococcus aureus (MRSA). After adjustment for age, sex, and the model for end-stage liver disease (MELD) score, only MRSA infection was an independent risk factor for 28-day mortality in the multivariable Cox proportional hazard regression model analysis (HR, 2.964, 95% CI (1.175-7.478), p = 0.021).

CONCLUSIONS

MDR bacterial infections, especially CRE, have become frequent in patients with cirrhosis in recent years, with MRSA infections significantly increasing short-term mortality.

摘要

背景

本研究旨在描述肝硬化患者中多重耐药(MDR)细菌引起的细菌感染的流行病学特征及其对死亡率的影响。

方法

对 2011 年至 2017 年间经培养证实的肝硬化合并细菌感染患者进行回顾性研究。

结果

共纳入 563 例肝硬化患者的 635 例次细菌感染。MDR 分离株引起的细菌感染占 635 例次的 44.1%(280/635),近一半为医院获得性感染(48.4%)。最常见的 MDR 分离部位是呼吸道(36.4%,102 例次),其次是腹腔(35.4%,99 例次)。MDR 分离株中,碳青霉烯类耐药肠杆菌科细菌(CRE)(91 例次)最为常见。感染 MDR 细菌的患者死亡率明显高于未感染的患者(25.1%比 17.4%,p=0.025)。然而,这种增加的死亡率在很大程度上归因于耐甲氧西林金黄色葡萄球菌(MRSA)。在校正年龄、性别和终末期肝病模型(MELD)评分后,只有 MRSA 感染是多变量 Cox 比例风险回归模型分析中 28 天死亡率的独立危险因素(HR,2.964,95%CI(1.175-7.478),p=0.021)。

结论

近年来,MDR 细菌感染,尤其是 CRE,在肝硬化患者中已变得频繁,MRSA 感染显著增加了短期死亡率。

相似文献

1
Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study.肝硬化患者的多重耐药菌感染:一项流行病学研究。
Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1167-1174. doi: 10.1080/17474124.2018.1515627. Epub 2018 Sep 5.
2
Epidemiological investigation of non-fermentative bacterial infection in cirrhotic patients.肝硬化患者非发酵菌感染的流行病学调查。
Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):815-820. doi: 10.1080/17474124.2019.1626716. Epub 2019 Jun 14.
3
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.肝硬化患者多重耐药菌感染的患病率及危险因素:一项前瞻性研究。
Hepatology. 2012 May;55(5):1551-61. doi: 10.1002/hep.25532. Epub 2012 Apr 4.
4
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.欧洲失代偿期肝硬化和慢加急性肝衰竭患者中的多重耐药菌感染。
J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.
5
Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.肿瘤患者多药耐药菌所致医院感染:中国西部某肿瘤中心六年回顾性研究。
BMC Infect Dis. 2020 Jun 29;20(1):452. doi: 10.1186/s12879-020-05181-6.
6
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.全球肝硬化患者细菌感染的流行病学和影响。
Gastroenterology. 2019 Apr;156(5):1368-1380.e10. doi: 10.1053/j.gastro.2018.12.005. Epub 2018 Dec 13.
7
Infection in cirrhosis: A prospective study.肝硬化感染:一项前瞻性研究。
Ann Hepatol. 2019 Nov-Dec;18(6):862-868. doi: 10.1016/j.aohep.2019.07.010. Epub 2019 Sep 5.
8
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany.德国肝硬化住院患者的细菌感染特征及多重耐药菌的流行情况
Ann Hepatol. 2022 Sep-Oct;27(5):100719. doi: 10.1016/j.aohep.2022.100719. Epub 2022 Apr 20.
9
The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study.印度耐多药病原体的死亡率负担:一项回顾性观察研究。
Clin Infect Dis. 2019 Aug 1;69(4):563-570. doi: 10.1093/cid/ciy955.
10
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey.多重耐药感染的传播导致肝硬化患者经验性抗生素治疗失败率上升:一项前瞻性调查。
PLoS One. 2015 May 21;10(5):e0127448. doi: 10.1371/journal.pone.0127448. eCollection 2015.

引用本文的文献

1
Clinical, Microbiological, and Antibiotic Treatment Characteristics of Bacterial Infections in Patients with Liver Cirrhosis in China: A Multicenter Study.中国肝硬化患者细菌感染的临床、微生物学及抗生素治疗特征:一项多中心研究
J Clin Transl Hepatol. 2025 Aug 28;13(8):644-654. doi: 10.14218/JCTH.2025.00211. Epub 2025 Jul 3.
2
Clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis.肝硬化患者多重耐药菌感染的临床影响
Future Sci OA. 2024 May 14;10(1):FSO945. doi: 10.2144/fsoa-2023-0160. eCollection 2024.
3
Colonization with Carbapenem-Resistant Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients.
耐碳青霉烯类细菌的定植会导致终末期肝病患者出现不良预后。
Antibiotics (Basel). 2022 Nov 20;11(11):1667. doi: 10.3390/antibiotics11111667.
4
Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study.澳大利亚肝硬化患者的菌血症、败血症和抗生素耐药性:一项基于人群的研究。
BMJ Open Gastroenterol. 2021 Dec;8(1). doi: 10.1136/bmjgast-2021-000695.
5
Current Concepts on Bacterial and Fungal Infections in Cirrhosis.肝硬化患者细菌和真菌感染的当前概念
Clin Liver Dis (Hoboken). 2019 Oct 9;14(3):87-91. doi: 10.1002/cld.799. eCollection 2019 Sep.